Popular esports tournament powers up at NRG Stadium with a historic twist

game on

Watch elite gamers face off in League of Legends. Photo by Jamie McInall/Pexels

Heads up, gamers. The most popular esport is coming to the Bayou City. The League Championship Series (LCS), will host its marquee championship event at NRG Stadium (8825 Kirby Dr.) on April 23 and 24, the organization announced.

Not only is this the first time the tournament will be held in Texas, it’s also the first time the prestigious League of Legends competition — the LCS Spring Finals — will be hosted in an NFL stadium. For the uninitiated, League of Legends is a wildly popular, team-based multiplayer strategy game.

Houston fans are invited to attend both the pregame Fan Fest celebration and the LCS Finals, a first since the pandemic. The Fan Fest starts at 10 am Saturday, April 23, and the first match starts at 2:30 pm.

As the league’s first seasonal championship event of the year, the competition will see North America’s top three teams vie for an LCS trophy, a banner in the LCS Studio rafters, and an invite to the international Mid-Season Invitational in Busan, South Korea next month, per a release.

Developed and run by influential and prolific developer and publisher Riot Games, this championship will be held in North America across four cities — Mexico City, New York City, Toronto and San Francisco, a first since 2016, a release notes.

As the most-watched esport in the world with 12 international leagues, the 10-year-old LCS is actually the third-most popular major professional sports league among 18- to 34-year-olds in the U.S., per industry insiders.

For some perspective, more than 465 million people watched esports in 2021. Esports generated more than $1 billion in revenue, according to a Newzoo report.

For more information on the Fan Fest and tournament, visit the official site.

------

This article originally ran on CultureMap.

Houston-based Mainline has announced new partnerships with a few universities. Jamie McInall/Pexels

Houston esports company taps nearby universities for partnerships

Game on

A Houston esports platform has announced that four universities — including one in town — have made moves to optimize the company's technology.

Texas A&M University, the University of Texas - Austin, Louisiana State University, and Houston's own University of St. Thomas have made a deal with Mainline. The company, which just closed a $9.8 million series A round, is a software and management platform for esports tournaments.

The four schools will use the software to host and grow their on-campus esports communities, according to a news release.

"These are top universities seeing the value of esports on-campus and making a choice to support their students' desires to play and compete — much like in traditional sports," says Chris Buckner, CEO at Mainline, in the release. "Adoption of Mainline is validation of the opportunity to engage students and the broader community with a compelling esports platform, as well as strengthen a school's brand, provide additional partnership opportunities and market their initiatives"

While UST has is still in the process of utilizing Mainline for its esports platform to grow its program and will use the software for its first tournament in 2020, A&M first used Mainline's software this past spring, but has doubled down on its commitment to esports.

"Texas A&M recognizes the significant esports presence on campus and the importance of supporting this thriving student community. Mainline allows us to maintain the brand continuity of the university, and to drive incremental inventory and value for sponsors," says Mike Wright, director of public relations and strategic communications at Texas A&M Athletics, in the release.

The platform provides its clients with an easy way to manage, monetize, and market their tournaments.

At UT, the school's administration, along with its Longhorn Gaming Club, is currently running two tournaments on Mainline: Rocket League and League of Legends.

"Texas has had a long established esports community on campus, and our partnership with Mainline will enable us to more closely work with Longhorn Gaming to better support this audience to benefit our students and partners," says Mike Buttersworth, director of the Center for Sports Communication and Media at UT, in the release.

Meanwhile at LSU, the university is running an esports Rocket League qualifying tournament on the Houston company's platform to select a three-student team to represent the school at the inaugural "Power Five Esports Invitational" in New York in January, according to the release.

"This kind of tournament is a first for our campus, and Mainline is making it easy for us to be able to host this qualifying tournament for our students to ultimately represent our university at the Power Five Esports invitational," says Robert Munson, senior associate athletics director at LSU.

As for Mainline, these four schools are just the beginning for universities using the platform.

"Mainline is continuing this collegiate momentum with another 10 powerhouse universities expected to come aboard our platform by the end of 2019, and 50 more by the spring 2020," says Buckner.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings